Olopatadine HCL 0.1% Ophthalmic Solution
View on SAM.gov ↗ Sign in to save
- Type
- Contract
- Notice type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Solicitation #
- SPE2D222R0117
- Posted
- May 4, 2026
- Archive date
- Feb 15, 2028
- NAICS
- 325412
- PSC
- 6505
- Place of performance
- Ontario, Canada, CAN
- Award amount
- $17,621,453
- Awardee
- GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
- Contact
- Kyle Lewicki · kyle.lewicki@dla.mil · 4457370977
- Source
- SAM.gov
Description
Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle